Beta
Thyroid hormone (levothyroxine, liothyronine)
medication Under reviewLevothyroxine and liothyronine are synthetic forms of the primary thyroid hormones produced by the human body: thyroxine (T4) and triiodothyronine (T3). Levothyroxine is a prohormone that is converted in peripheral tissues to the active T3, while liothyronine is synthetic T3 itself and exerts more rapid and potent physiological effects. Together, they act through nuclear thyroid hormone receptors to regulate gene transcription and protein synthesis across multiple organ systems. These hormones play central roles in energy expenditure, cellular oxidation, growth and maturation of tissues, development and function of the nervous system, and carbohydrate and protein metabolism. In clinical practice they are used primarily as prescription medications to replace deficient endogenous thyroid hormone, restore euthyroid status, suppress thyroid-stimulating hormone (TSH) in certain thyroid cancers, and as diagnostic tools in thyroid function tests. Outside of disease treatment, thyroid hormone influences metabolic rate, body temperature regulation, cardiovascular function, and cognitive performance, but deliberate use in healthy euthyroid individuals is not recommended because of the narrow therapeutic window and risk of inducing hyperthyroidism. Levothyroxine is the standard first-line therapy because its longer half-life allows for stable once-daily dosing and steady serum T4 and TSH levels. Liothyronine has a faster onset and greater potency but shorter duration, leading to more fluctuation in T3 levels. Combination therapy using both hormones has been explored to better mimic physiological thyroid hormone balance; however, current evidence does not support routine use in people with normal thyroid function and highlights potential for adverse effects when supraphysiologic doses are used.
Research summary
Most clinical research on levothyroxine and liothyronine involves patients with hypothyroidism or other thyroid disorders rather than healthy euthyroid individuals. In these populations, levothyroxine alone generally normalizes serum TSH and improves symptoms, but some tissue-level markers and patient-reported outcomes may remain suboptimal in a subset of patients, prompting investigation of combination T4/T3 therapy. Multiple randomized controlled trials and meta-analyses comparing levothyroxine monotherapy with levothyroxine plus liothyronine have found no consistent improvements in quality of life, mood, cognitive performance, body weight, or cardiovascular and metabolic parameters when TSH is kept in the reference range. There is very limited direct interventional research in completely healthy humans given thyroid hormone solely for performance, mood, weight loss, or cognitive enhancement. Evidence from replacement and suppression studies indicates that increasing thyroid hormone above physiologic levels can raise energy expenditure and influence metabolic markers, but at the cost of symptoms and signs of hyperthyroidism, bone turnover acceleration, and cardiovascular strain. Overall, the research consensus is that thyroid hormone therapy should be reserved for clearly documented thyroid hormone deficiency or specific oncologic and diagnostic indications, and not used as a general-purpose supplement in healthy individuals.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Thyroid hormone (levothyroxine, liothyronine) to your stack to report effects
Levothyroxine: Conventional and Novel Drug Delivery Formulations
Kasaoka S, Masaki T, Yamazaki M, et al.
Combined Levothyroxine Plus Liothyronine Compared With Levothyroxine Alone in Primary Hypothyroidism
Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr.
Treatment of hypothyroidism with levothyroxine plus slow-release liothyronine: a study protocol for a randomized controlled double-blinded clinical trial.
Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP
Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document.
Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, McDermott MT, Ross DS, Sawka AM
No reports yet
Be the first to report this effect and help the community.
Add Thyroid hormone (levothyroxine, liothyronine) to your stack to report effects
Treatment of hypothyroidism with levothyroxine plus slow-release liothyronine: a study protocol for a randomized controlled double-blinded clinical trial.
Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP
Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document.
Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, McDermott MT, Ross DS, Sawka AM
Combined Levothyroxine Plus Liothyronine Compared With Levothyroxine Alone in Primary Hypothyroidism
Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr.
No reports yet
Be the first to report this effect and help the community.
Add Thyroid hormone (levothyroxine, liothyronine) to your stack to report effects
Combined Levothyroxine Plus Liothyronine Compared With Levothyroxine Alone in Primary Hypothyroidism
Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr.
Treatment of hypothyroidism with levothyroxine plus slow-release liothyronine: a study protocol for a randomized controlled double-blinded clinical trial.
Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP
Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document.
Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, McDermott MT, Ross DS, Sawka AM
No reports yet
Be the first to report this effect and help the community.
Add Thyroid hormone (levothyroxine, liothyronine) to your stack to report effects
Levothyroxine: Conventional and Novel Drug Delivery Formulations
Kasaoka S, Masaki T, Yamazaki M, et al.
Treatment of hypothyroidism with levothyroxine plus slow-release liothyronine: a study protocol for a randomized controlled double-blinded clinical trial.
Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP
No reports yet
Be the first to report this effect and help the community.
Add Thyroid hormone (levothyroxine, liothyronine) to your stack to report effects
Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document.
Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, McDermott MT, Ross DS, Sawka AM
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Related health conditions
Research showing how this habit affects specific health conditions. Always consult healthcare professionals.
May Help With
Underactive thyroid producing too little thyroid hormone
Combined Levothyroxine Plus Liothyronine Compared With Levothyroxine Alone in Primary Hypothyroidism
Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr.
Treatment of hypothyroidism with levothyroxine plus slow-release liothyronine: a study protocol for a randomized controlled double-blinded clinical trial.
Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP
Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document.
Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, McDermott MT, Ross DS, Sawka AM
Levothyroxine: Conventional and Novel Drug Delivery Formulations
Kasaoka S, Masaki T, Yamazaki M, et al.
Research (4 studies)
Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document.
Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, McDermott MT, Ross DS, Sawka AM
Levothyroxine: Conventional and Novel Drug Delivery Formulations
Kasaoka S, Masaki T, Yamazaki M, et al.
Treatment of hypothyroidism with levothyroxine plus slow-release liothyronine: a study protocol for a randomized controlled double-blinded clinical trial.
Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP
Combined Levothyroxine Plus Liothyronine Compared With Levothyroxine Alone in Primary Hypothyroidism
Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr.
Community updates
No updates yet for this supplement.
Be the first to share your experience!